Navigation Links
Warwick scientists discover how daughter cells receive the same number of chromosomes
Date:11/1/2011

Scientists at Warwick Medical School have uncovered the molecular process of how cells are by-passing the body's inbuilt 'health checkpoint' with cells that carry unequal numbers of chromosomes that have a higher risk of developing cancer.

Studying simple yeast cells, scientists now understand the mechanism by which cells ensure their daughter cells receive the correct number of chromosomes.

Most cells in our bodies contain 23 pairs of chromosomes that encode our individual genetic identities. In healthy, dividing human cells, each of these chromosomes is duplicated and one copy passed to each of the two daughter cells. However, if this process is disturbed, daughter cells receive an unequal number of chromosomes, a state that is known to drive normal cells to become cancerous. In fact, aggressive human tumours are frequently composed of cells with an abnormal complement of chromosomes.

Professor Jonathan Millar explained: "This cell division process is monitored by the body's surveillance system known as the 'spindle checkpoint', and that is only switched off once everything within the cell is set up correctly. Amazingly, all of the elements of this process are conserved from yeast to human cells. Therefore it is extremely likely that what we have found in yeast also happens in human cells. So by preventing this process happening with drugs, you could restrict the cell's ability to develop into full blown cancer," explained Professor Millar.

Currently, one of the most frequently used classes of anti-cancer drugs are taxanes, which target the mitotic apparatus in part by preventing proper silencing of the spindle checkpoint. However, this class of drug affects healthy and cancerous cells alike and can have debilitating side effects including permanent neurological damage and hair loss.

Professor Millar explained: "Now that we have pinpointed the central elements of cell division, we are in a great position to design drugs that can be more selective and targeted about which cells they treat. But this is just the start much more research has to be done before we can convert this into a commercial treatment for patients, but we are greatly encouraged that our research here at Warwick is leading the way in the search for more effective cancer treatments with fewer side effects."


'/>"/>

Contact: Kate Cox
kate.cox@warwick.ac.uk
University of Warwick
Source:Eurekalert

Related medicine news :

1. NIH scientists discover link among spectrum of childhood diseases
2. Scientists Identify Gene Linked to Cold Sores
3. Scientists prove regular aspirin intake halves cancer risk
4. Scientists make strides toward drug therapy for inherited kidney disease
5. SMU scientists to lead water quality study at UN refugee camps
6. How hemp got high: Canadian scientists map the cannabis genome
7. UGA scientists team up to define first-ever sequence of biologically important carbohydrate
8. Scientists in Singapore and Europe to collaborate
9. Scientists Spot New Clues to HIV-Linked Dementia
10. Scientists Engineer Mice That Have Autism
11. Raw Sewage a New Frontier for Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: